Disease block
N10-N16 – Tubulointerstitielle Nierenkrankheiten
- Chapter XIV: Krankheiten des Urogenitalsystems
8Decisions
10Patient groups
Added benefit by patient group
- Non-quantifiable1
- Deemed proven9
Diseases in this disease block
- N10 Akute tubulointerstitielle Nephritis 7 decisions
- N11 Chronische tubulointerstitielle Nephritis 8 decisions
- N12 Tubulointerstitielle Nephritis, nicht als akut oder chronisch bezeichnet 7 decisions
- N13 Obstruktive Uropathie und Refluxuropathie 7 decisions
- N15 Sonstige tubulointerstitielle Nierenkrankheiten 7 decisions
Decisions, newest first
Each decision lists only the patient groups coded with a disease in this disease block.
- 2026-09-03UpliznaInebilizumabNon-quantifiable
- 2025-05-15ZaviceftaCeftazidim/AvibactamDeemed proven
- 2025-04-17VaboremMeropenem/VaborbactamDeemed proven
- 2025-02-20EmblaveoAztreonam/AvibactamDeemed proven
- 2024-12-05ExblifepCefepim/EnmetazobactamDeemed proven
- 2023-02-02ZerbaxaCeftolozan/TazobactamDeemed proven: 2 of 2 patient groups
- 2022-11-03ZaviceftaCeftazidim/AvibactamDeemed proven
- 2022-11-03ZerbaxaCeftolozan/TazobactamDeemed proven: 2 of 2 patient groups
Data status: 2026-10-29